People With HIV On ART Regimens Using Integrase Strand Transfer Inhibitors At Increased Risk For Diabetes, Hyperglycemia Within First Six Months Of Treatment, Study Suggests

Healio (5/22, Stulpin) reports, “People with HIV who are on ART regimens using integrase strand transfer inhibitors are at an increased risk for diabetes or hyperglycemia within the first 6 months of treatment, researchers found.” The study findings – pub...